Surgery Partners (NASDAQ:SGRY) Price Target Lowered to $34.00 at Macquarie

Surgery Partners (NASDAQ:SGRYGet Free Report) had its price target reduced by equities researchers at Macquarie from $35.00 to $34.00 in a report issued on Wednesday,Benzinga reports. The firm currently has an “outperform” rating on the stock. Macquarie’s target price would suggest a potential upside of 37.26% from the company’s current price.

SGRY has been the topic of several other research reports. StockNews.com lowered Surgery Partners from a “hold” rating to a “sell” rating in a research note on Wednesday, August 7th. Royal Bank of Canada reissued an “outperform” rating and set a $49.00 target price on shares of Surgery Partners in a research report on Wednesday, August 7th. KeyCorp initiated coverage on shares of Surgery Partners in a research report on Friday, October 11th. They issued a “sector weight” rating for the company. UBS Group assumed coverage on shares of Surgery Partners in a report on Monday, October 14th. They set a “buy” rating and a $38.00 price objective on the stock. Finally, Benchmark reissued a “buy” rating and issued a $50.00 price objective on shares of Surgery Partners in a research note on Monday, August 26th. One analyst has rated the stock with a sell rating, two have given a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat, Surgery Partners currently has a consensus rating of “Moderate Buy” and a consensus price target of $40.71.

Check Out Our Latest Report on Surgery Partners

Surgery Partners Trading Down 2.9 %

Shares of NASDAQ:SGRY opened at $24.77 on Wednesday. The business’s 50 day moving average is $30.88 and its 200 day moving average is $28.47. Surgery Partners has a 52-week low of $22.25 and a 52-week high of $36.92. The company has a debt-to-equity ratio of 0.99, a current ratio of 1.80 and a quick ratio of 1.69.

Institutional Trading of Surgery Partners

Several hedge funds and other institutional investors have recently made changes to their positions in the business. Arizona State Retirement System raised its holdings in shares of Surgery Partners by 1.9% in the second quarter. Arizona State Retirement System now owns 19,494 shares of the company’s stock worth $464,000 after buying an additional 359 shares during the last quarter. Natixis Advisors LLC increased its position in shares of Surgery Partners by 3.0% in the 3rd quarter. Natixis Advisors LLC now owns 12,828 shares of the company’s stock valued at $414,000 after acquiring an additional 376 shares during the period. KBC Group NV lifted its position in Surgery Partners by 31.8% during the 3rd quarter. KBC Group NV now owns 2,385 shares of the company’s stock worth $77,000 after acquiring an additional 576 shares during the period. Mackenzie Financial Corp grew its stake in Surgery Partners by 3.4% during the 2nd quarter. Mackenzie Financial Corp now owns 19,999 shares of the company’s stock valued at $476,000 after purchasing an additional 662 shares during the last quarter. Finally, ProShare Advisors LLC increased its holdings in shares of Surgery Partners by 7.8% in the first quarter. ProShare Advisors LLC now owns 13,588 shares of the company’s stock valued at $405,000 after purchasing an additional 986 shares during the period.

Surgery Partners Company Profile

(Get Free Report)

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.

Featured Stories

Analyst Recommendations for Surgery Partners (NASDAQ:SGRY)

Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.